Correlation Between Iovance Biotherapeutics and Cue Biopharma

Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Iovance Biotherapeutics and Cue Biopharma, you can compare the effects of market volatilities on Iovance Biotherapeutics and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Cue Biopharma.

Diversification Opportunities for Iovance Biotherapeutics and Cue Biopharma

-0.4

Correlation Coefficient

Iovance Biotherapeutics  Cue Biopharma

Very good diversification

The 3 months correlation between Iovance and Cue is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Cue Biopharma go up and down completely randomly.

Pair Corralation between Iovance Biotherapeutics and Cue Biopharma

Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 0.98 times more return on investment than Cue Biopharma. However, Iovance Biotherapeutics is 1.02 times less risky than Cue Biopharma. It trades about 0.1 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.04 per unit of risk. If you would invest  810.00  in Iovance Biotherapeutics on February 1, 2024 and sell it today you would earn a total of  368.00  from holding Iovance Biotherapeutics or generate 45.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Iovance Biotherapeutics  vs.  Cue Biopharma

Iovance Biotherapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Iovance Biotherapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Iovance Biotherapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Cue Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cue Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in June 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Iovance Biotherapeutics and Cue Biopharma

The main advantage of trading using opposite Iovance Biotherapeutics and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.

The idea behind Iovance Biotherapeutics and Cue Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.